2 results
Approved WMOCompleted
The co-primary objectives of this study are: * To evaluate the efficacy of as measured by investigator-assessed PFS according to Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1). * To evaluate the efficacy of atezolizumab as…
Approved WMORecruiting
To compare two (standard) treatment regimens in patients with KRAS mutated advanced stage NSCLC as first line treatment.